🇺🇸 MRK — Merck & Co., Inc.
Salud CompraPrecio actual
146,73 USD
Máx. histórico
156,45
73 días
Split 1048:1000 del 03/06/2021
Caída desde máximo
-6,21%
Rango 52 semanas
85,24 – 156,92
Variación hoy
-0,14%
Cierre anterior
146,94
Rango de hoy
142,80 – 147,48
Volumen hoy
7.462.267
Peor caída histórica
-68,62%
28/12/2000 → 09/03/2009
Recuperado en 1796 días
Volatilidad anualizada ⓘ
25,43%
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Salud
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 148,21 (puede no estar actualizado)
- Dividend yield
- 2,31% (puede no estar actualizado)
- Precio objetivo analistas
- 161,53 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 20 horas
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 15/09/2026 | 0,8500 USD |
| 15/06/2026 | 0,8500 USD |
| 16/03/2026 | 0,8500 USD |
| 15/12/2025 | 0,8500 USD |
| 15/09/2025 | 0,8100 USD |
| 16/06/2025 | 0,8100 USD |
| 17/03/2025 | 0,8100 USD |
| 16/12/2024 | 0,8100 USD |
| 16/09/2024 | 0,7700 USD |
| 17/06/2024 | 0,7700 USD |
| 14/03/2024 | 0,7700 USD |
| 14/12/2023 | 0,7700 USD |
| 14/09/2023 | 0,7300 USD |
| 14/06/2023 | 0,7300 USD |
| 14/03/2023 | 0,7300 USD |
| Fecha | Ratio |
|---|---|
| 03/06/2021 | 1048:1000 |
| 17/02/1999 | 2:1 |
| 26/05/1992 | 3:1 |
| 26/05/1988 | 3:1 |
| 27/05/1986 | 2:1 |
| 01/06/1972 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 03/01/1986 | 3,66 | 3,73 | 3,65 | 3,72 | +1,81% | 2,18% | 8.639.712 |
| 02/01/1986 | 3,63 | 3,66 | 3,62 | 3,66 | +0,73% | 0,91% | 8.635.939 |
| 31/12/1985 | 3,61 | 3,65 | 3,60 | 3,63 | +0,46% | 1,29% | 7.443.734 |
| 30/12/1985 | 3,60 | 3,62 | 3,59 | 3,61 | +0,55% | 0,64% | 4.700.909 |
| 27/12/1985 | 3,55 | 3,60 | 3,55 | 3,59 | +1,78% | 1,49% | 5.368.694 |
| 26/12/1985 | 3,51 | 3,54 | 3,51 | 3,53 | +0,66% | 0,76% | 3.304.973 |
| 24/12/1985 | 3,51 | 3,51 | 3,49 | 3,51 | -0,19% | 0,66% | 4.580.179 |
| 23/12/1985 | 3,57 | 3,57 | 3,51 | 3,52 | -1,58% | 1,76% | 4.942.368 |
| 20/12/1985 | 3,59 | 3,62 | 3,57 | 3,57 | -0,55% | 1,29% | 15.426.979 |
| 19/12/1985 | 3,56 | 3,60 | 3,56 | 3,59 | +0,65% | 1,21% | 5.779.930 |
| 18/12/1985 | 3,58 | 3,60 | 3,56 | 3,57 | -0,65% | 1,20% | 7.300.368 |
| 17/12/1985 | 3,64 | 3,64 | 3,59 | 3,59 | -1,00% | 1,36% | 7.243.776 |
| 16/12/1985 | 3,57 | 3,64 | 3,55 | 3,63 | +1,76% | 2,41% | 9.232.042 |
| 13/12/1985 | 3,55 | 3,57 | 3,53 | 3,57 | +1,13% | 1,12% | 6.711.811 |
| 12/12/1985 | 3,57 | 3,58 | 3,52 | 3,53 | -0,93% | 1,67% | 5.436.605 |
| 11/12/1985 | 3,51 | 3,57 | 3,51 | 3,56 | +1,51% | 1,51% | 8.239.795 |
| 10/12/1985 | 3,49 | 3,52 | 3,49 | 3,51 | +0,48% | 0,76% | 6.821.222 |
| 09/12/1985 | 3,47 | 3,50 | 3,47 | 3,49 | +1,25% | 0,86% | 6.613.718 |
| 06/12/1985 | 3,48 | 3,48 | 3,42 | 3,45 | -0,76% | 1,62% | 8.236.022 |
| 05/12/1985 | 3,48 | 3,53 | 3,47 | 3,47 | +0,38% | 1,72% | 10.439.338 |
| 04/12/1985 | 3,42 | 3,47 | 3,41 | 3,46 | +1,46% | 1,74% | 5.304.557 |
| 03/12/1985 | 3,41 | 3,42 | 3,39 | 3,41 | -0,48% | 0,78% | 3.704.890 |
| 02/12/1985 | 3,46 | 3,47 | 3,41 | 3,43 | -0,58% | 1,72% | 5.930.842 |
| 29/11/1985 | 3,47 | 3,49 | 3,43 | 3,45 | -0,67% | 1,53% | 6.915.542 |
| 27/11/1985 | 3,39 | 3,47 | 3,39 | 3,47 | +3,46% | 2,34% | 13.857.494 |
| 26/11/1985 | 3,33 | 3,38 | 3,31 | 3,35 | +0,80% | 2,19% | 6.115.709 |
| 25/11/1985 | 3,34 | 3,34 | 3,32 | 3,33 | -0,30% | 0,50% | 3.406.838 |
| 22/11/1985 | 3,30 | 3,34 | 3,30 | 3,34 | +0,90% | 1,31% | 9.824.371 |
| 21/11/1985 | 3,23 | 3,31 | 3,22 | 3,31 | +2,78% | 2,77% | 6.840.086 |
| 20/11/1985 | 3,22 | 3,22 | 3,21 | 3,22 | -0,10% | 0,31% | 2.961.648 |